Go or no go? August FDA decisions for Axsome, Sanofi and Merck

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 30, 2021 at 11:12 AM.

  1. #1 cafead, Jul 30, 2021 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Axsome and Sanofi face FDA verdicts in depression and Pompe disease respectively, while a Keytruda combo ups the ante in kidney cancer.

    article source
     
    Quote

Reply to Thread